AI Financial Corp

Listed Company
AIFCCIK 0000862861NasdaqNon-AcceleratedSmaller ReportingCommodity Contracts Brokers & DealersNevadaFY ends Dec 26
Period
FY 2025
Revenue
$24.84M
Net Income
$-344.51M
Total Assets
Equity
Shares Out
139.84M
Op. Cash Flow
$-7.16M

Business

ALT5 Sigma Corp provides blockchain-powered financial services and clinical-stage biotechnology development through distinct Fintech and Biotechnology segments. Its Fintech business offers ALT5 Pay, a crypto payment gateway, and ALT5 Prime, an OTC electronic trading platform available via browser, mobile app, FIX API and third-party gateways. Its Biotechnology business develops non-opioid pain therapies, principally JAN101 (sustained-release sodium nitrite) and JAN123 (biphasic low-dose naltrexone). The company targets institutional B2B clients — banks, broker‑dealers, funds, family offices, liquidity providers and merchants — across the United States, Canada, Europe and other global markets.

Summary from filing dated 2025-03-28

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts
ConceptTrend
FY 2025
2025-12-31
FY 2024
2024-12-31
FY 2023
2023-12-31
FY 2022
2022-12-31
FY 2021
2021-12-31
Revenues25120040
Cost of revenues1560031
Gross profit106009
Selling, general and administrative expenses33135312
Total operating expenses331320312
Operating loss−23−7−20−3−17
Interest expense, net−4−12
Realized gain on exchange transactions374,00010
Unrealized loss on cryptocurrency assets−402
Unrealized gain on exchange transactions768,000
Unrealized loss on marketable securities−1−926,000−631,0000
Other expense, net−596,000−160,000998,0002152,000
Total other expense, net−405−225180,000
Loss before benefit from income taxes−428−8−181−3
Income tax benefit−87−160,000−400,000−7273,000
Net loss from continuing operations−341−8
Loss from discontinued operations−4−2105
Income tax benefit for discontinued operations−877,000−3971,0002
Net (loss) income from discontinued operations−3733,000
Net loss−345−8−811−17
Net loss per share from continuing operations, basic−5.86−0.74−4.272.55−1.25
Net loss per share from continuing operations, diluted−5.86−0.74−4.272.55−1.25
Net loss per share, basic−5.91−0.68−1.953.49−6.35
Net loss per share, diluted−5.91−0.68−1.953.49−6.35
Basic5811433
Diluted5811433
Effect of foreign currency translation adjustments−4−20−4,000−29,000
Total other comprehensive loss, net of tax−4−2
Comprehensive (loss) income−348−10−811−17

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro